Intercure Ltd. current report, Q4 FY2022

Business Context and Reporting Period

InterCure Ltd., an Israeli foreign private issuer, filed Form 6-K for November 2022 on November 17, 2022. The filing identifies Exhibit 99.1 as a press release dated November 17, 2022, but the press release text is not included in the provided filing content.

Financial Metrics

The provided filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.

Material Changes Versus Prior Period

The filing text does not describe material changes versus a prior comparable period.

Guidance, Outlook, Risks, and Unusual Items

The filing text does not provide guidance, outlook, management commentary, risk disclosures, contingencies, or unusual items. These matters may be addressed in Exhibit 99.1, which is referenced but not reproduced.

Important Facts to Verify

  • Obtain and review Exhibit 99.1, the November 17, 2022 press release.
  • Verify whether the press release contains financial results, operational updates, guidance, or material corporate developments.
  • Confirm any reported metrics, risks, contingencies, and management commentary directly against the complete exhibit.